REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g 4 Regulatory News (MIG4)

Share Price Information for Mobeus I&g 4 (MIG4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.00
Bid: 66.50
Ask: 69.50
Change: 0.00 (0.00%)
Spread: 3.00 (4.511%)
Open: 68.00
High: 68.00
Low: 68.00
Prev. Close: 68.00
MIG4 Live PriceLast checked at -
Mobeus Income & Growth 4 VCT is an Investment Trust

To provide investors with a regular income stream and to generate capital growth by investing primarily in a diverse portfolio of UK unquoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed change in management arrangements

10 Sep 2021 07:06

RNS Number : 3876L
Income & Growth VCT (The) PLC
10 September 2021
 

10 September 2021

Mobeus Income & Growth VCT plc

LEI: 213800HKOSEVWS7YPH79

Mobeus Income & Growth 2 VCT plc

LEI: 213800LY62XLI1B4VX35

Mobeus Income & Growth VCT 4 plc -

LEI: 213800IFNJ65R8AQW943

The Income & Growth VCT plc

LEI: 213800FPC15FNM74YD92

(together the Mobeus VCTs)

Proposed change in management arrangements

The boards of the Mobeus VCTs (Boards) advise that Mobeus Equity Partners LLP (Mobeus), the investment adviser to the Mobeus VCTs, has today announced the sale of its VCT fund and investment management business to a subsidiary of Gresham House plc (Gresham House). As part of the sale, the Boards have agreed to the novation of the investment advisory arrangements from Mobeus to Gresham House subject to completion of the sale.

Gresham House and the enlarged VCT team

Gresham House is a specialist alternative asset manager listed on the London Stock Exchange with £4.7 billion in assets under management (at 30 June 2021). Gresham House is a fast growing, specialist fund group, with a long-term commitment to the VCT industry and is the existing investment manager of the Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc (the Baronsmead VCTs).

Mobeus and Baronsmead are two of the leading names in the VCT industry. The transaction combines two investment and operations teams with market-leading track records, each with more than 20 years' heritage and experience, creating a significant platform in the VCT market across over £850 million of shareholders' funds. Each of the Mobeus VCTs' and the Baronsmead VCTs' brands will retain their individual investment strategies to offer investors the choice of two high-quality offerings. The Mobeus VCTs will remain focused on unquoted investments, whilst the Baronsmead VCTs will continue to invest in both unquoted and public companies traded on AIM.

The entire core management, investment and operational teams involved with the Mobeus VCTs will all transfer to Gresham House in connection with this transaction to form a significant enlarged team that will manage both the Mobeus VCTs and the Baronsmead VCTs. A wide-ranging multi-year agreement has been put in place between Mobeus and Gresham House to enable a smooth transition and continuity of management of the VCTs (including continuing to use the 'Mobeus' name for a period). 

The Boards are pleased that Trevor Hope and Clive Austin, the two leading partners involved with managing the Mobeus VCTs' investment portfolios, are joining Bevan Duncan and Ken Wotton, who lead the investment management of the Baronsmead VCTs, in becoming the senior management team of the Strategic Equity division within Gresham House. Trevor and Clive will remain responsible for the investment, portfolio, and fund management of the Mobeus VCTs, alongside their investment and operations teams. They will be supported in the transition by Mobeus founder partners Mark Wignall and Rob Brittain who will act as consultants to Gresham House.

The Boards' considerations

After careful consideration and due diligence, the Boards believe that consenting to the novation of the investment advisory arrangements is in the interests of the Mobeus VCTs' shareholders. The Boards expect the creation of the enlarged VCT team to be well received by the market as creating an exciting and potent commercial force that should lead to enhanced prospects for Shareholders. In the context of a VCT sector that is evolving, this view is predicated on:

· Scale Advantage - The integration of the Mobeus and Baronsmead VCT teams within Gresham House creates one of the largest VCT teams in the sector with the coverage, experience, contacts and know how to access more and higher quality investment opportunities. The greater breadth and depth of resource in portfolio and talent management should also be valuable in assisting the Mobeus VCTs' existing portfolio companies to grow successfully.

· Continuity - Trevor Hope and Clive Austin will continue to lead the VCT team and will be supported in the transition by Mark Wignall and Rob Brittain. This management group is well known and has been highly regarded by shareholders for a considerable period. The Boards are confident that the team will continue to build the Mobeus VCTs' portfolios and enhance their value. Gresham House's investment philosophy is similar to that developed over many years by Mobeus, and the procedure for undertaking due diligence and approving new investments will be substantially the same as before.

· Portfolio Diversification - The access to a much larger asset base and investment opportunities should enable the combined VCT investment team to build more diversified VCT portfolios across a broader range of sizes and stages of investment. The Boards believe that this combined VCT investment team will be a major force in the supply of capital to the VCT sector and it is anticipated that the team's enhanced market position should attract strong deal flow.

· Investment in Capability - The Mobeus VCT investment team has delivered outstanding performance over many years, but it has become clear that the changing demands of the market mean that the requirement for additional investment in people, technology and processes could become constrained within the framework of the existing Mobeus partnership structure.

The Boards can confirm that no material changes are being made to the terms of the investment advisory arrangements. Shareholders can also be assured that the Boards' track record of governance and independence will be maintained.

Timetable and conclusions

The Boards consider that the change in management and advisory arrangements is in the interests of Shareholders and look forward to working with Gresham House to achieve a continued strong investment performance for the Mobeus VCTs' shareholders.

The sale, and consequently the novation of the Mobeus VCTs' investment advisory arrangements, will take effect on or around 1 October 2021 following satisfaction of a number of technical conditions and completion by Gresham House of a placing to fund the acquisition.

The Boards are also aware that there is strong demand to subscribe for new shares in the Mobeus VCTs. As such, the Boards will, following completion of the novation of their investment advisory arrangements to Gresham House, be considering raising new additional funds and launching offers for subscription in the 2021/2022 tax year. Further announcements will be made in due course.

For further information please contact:

 

Trish Standaloft

Mobeus Equity Partners LLP

Company Secretary

 

Tel: 020 7024 7616

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCURRNRAOUKARR
Date   Source Headline
1st May 20247:00 amRNSTotal Voting Rights and Capital
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20247:00 amRNSAnnual Financial Report
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
22nd Mar 202410:02 amRNSDirector/PDMR Shareholding
22nd Mar 202410:00 amRNSIssue of Equity and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
22nd Feb 202411:00 amRNSNet Asset Value(s)
6th Feb 20243:00 pmRNSDividend Declaration
1st Feb 202411:44 amRNSVoting Rights and Capital
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202310:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
27th Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20232:00 pmRNSInterim Management Statement - replacement
15th Nov 20233:00 pmRNSInterim Management Statement
8th Nov 202310:35 amRNSDirector/PDMR Shareholding
8th Nov 202310:30 amRNSIssue of Equity and Total Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
18th Oct 202310:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSStatement re Change of Registrar
5th Oct 20237:00 amRNSDividend Declaration
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20237:00 amRNSHalf-year Report
22nd Sep 20237:00 amRNSDirector Declaration
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:00 pmRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTotal Voting Rights
26th May 20232:24 pmRNSDirector/PDMR Shareholding
26th May 202312:57 pmRNSIssue of Equity and Total Voting Rights
25th May 20237:00 amRNSResult of AGM
23rd May 20237:00 amRNSInterim Management Statement
2nd May 202310:00 amRNSTotal Voting Rights
19th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20231:00 pmRNSDividend Declaration
6th Apr 20237:00 amRNSAnnual Financial Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
1st Mar 20237:00 amRNSTotal Voting Rights
6th Feb 20235:28 pmRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:08 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
22nd Dec 20229:34 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.